GWG Holdings Reschedules Third Quarter 2018 Filing, Earnings Release and Webcast

  • November 14, 2018
  • Home
  • USA
  • GWG Holdings Reschedules Third Quarter 2018 Filing, Earnings Release and Webcast

MINNEAPOLIS, Nov. 14, 2018 (GLOBE NEWSWIRE) — GWG Holdings, Inc. (Nasdaq: GWGH), a leading provider of liquidity to consumers owning life insurance policies, an owner of a portfolio of alternative assets, and the developer of epigenetic technology for the life insurance industry, announced that it will file its Quarterly Report on Form 10-Q and issue the press release for the third quarter of 2018 on Monday, November 19, 2018. The additional time allows for the Company to complete the review of its financial statements and disclosures with its independent auditors.

As a result, the Company will reschedule its quarterly earnings webcast to Wednesday, November 21 at 8:30 a.m. EST.

About GWG Holdings, Inc.

GWG Holdings, Inc. (Nasdaq: GWGH), the parent company of GWG Life, Life Epigenetics and YouSurance, is a leading provider of liquidity to consumers owning life insurance policies, an owner of a portfolio of alternative assets, and the developer of epigenetic technology for the life insurance industry and beyond. GWG Life provides value to consumers owning illiquid life insurance products across America, delivering them more than $525 million for their policies since 2006. GWG Life owns a portfolio valued at $1.85 billion in face value of policy benefits as of June 30, 2018. Life Epigenetics is commercializing epigenetic technology to transform life insurance underwriting and risk assessment. YouSurance, a digital life insurance agency, is working to embed epigenetic testing into life insurance purchasing to provide consumers a value-added digital ecosystem that supports their health and wellness while reducing the cost of their insurance.

For more information about GWG Holdings, email [email protected] or visit www.gwgh.com.

Media Contact:

Dan Callahan
Director of Communication
GWG Holdings, Inc.
(612) 746-1935
[email protected]